1. Home
  2. PRTA vs ACEL Comparison

PRTA vs ACEL Comparison

Compare PRTA & ACEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • ACEL
  • Stock Information
  • Founded
  • PRTA 2012
  • ACEL 2009
  • Country
  • PRTA Ireland
  • ACEL United States
  • Employees
  • PRTA N/A
  • ACEL N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • ACEL Services-Misc. Amusement & Recreation
  • Sector
  • PRTA Health Care
  • ACEL Consumer Discretionary
  • Exchange
  • PRTA Nasdaq
  • ACEL Nasdaq
  • Market Cap
  • PRTA 809.8M
  • ACEL 818.8M
  • IPO Year
  • PRTA N/A
  • ACEL N/A
  • Fundamental
  • Price
  • PRTA $9.20
  • ACEL $11.05
  • Analyst Decision
  • PRTA Buy
  • ACEL Strong Buy
  • Analyst Count
  • PRTA 9
  • ACEL 2
  • Target Price
  • PRTA $54.57
  • ACEL $16.00
  • AVG Volume (30 Days)
  • PRTA 557.1K
  • ACEL 506.2K
  • Earning Date
  • PRTA 05-07-2025
  • ACEL 05-07-2025
  • Dividend Yield
  • PRTA N/A
  • ACEL N/A
  • EPS Growth
  • PRTA N/A
  • ACEL N/A
  • EPS
  • PRTA N/A
  • ACEL 0.41
  • Revenue
  • PRTA $135,157,000.00
  • ACEL $1,230,972,000.00
  • Revenue This Year
  • PRTA N/A
  • ACEL $8.29
  • Revenue Next Year
  • PRTA $131.71
  • ACEL $4.28
  • P/E Ratio
  • PRTA N/A
  • ACEL $27.17
  • Revenue Growth
  • PRTA 47.92
  • ACEL 5.17
  • 52 Week Low
  • PRTA $9.10
  • ACEL $9.02
  • 52 Week High
  • PRTA $25.42
  • ACEL $12.96
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 26.58
  • ACEL 60.99
  • Support Level
  • PRTA $9.30
  • ACEL $9.02
  • Resistance Level
  • PRTA $10.45
  • ACEL $10.89
  • Average True Range (ATR)
  • PRTA 0.81
  • ACEL 0.41
  • MACD
  • PRTA -0.15
  • ACEL 0.17
  • Stochastic Oscillator
  • PRTA 2.77
  • ACEL 88.86

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About ACEL Accel Entertainment Inc.

Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.

Share on Social Networks: